IP Library Granted Patent US 9,180,177
Granted Patent B2
US 9,180,177 · App. 14/188,825 · Granted Nov 10, 2015

Bacterial ribonucleic acid cell wall compositions and methods of making and using them

Inventors: Nigel C. Phillips (Pointe-Claire, CA); Danbing Ke (Kirkland, CA); Zdenek Richard Holan (Montreal, CA); Mohamed Elrafih (Belleville, CA)
Assignee: Bioniche Urology IP Inc.
A61K39/04A61K31/7105A61K35/74A61K39/39C12N1/06A61K2039/53A61K2039/55555A61K2039/55594
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,180,177
App. No.
14/188,825
Granted
Nov 10, 2015
Kind
B2
Abstract

The present invention relates to novel bacterial and mycobacterial compositions containing RNA and cell walls, and methods for making and using these compositions. These compositions have immune stimulating and anti-cancer activity.

Claims (54)

1. A method of making a composition comprising isolated mycobacterial RNA associated with mycobacterial cell wall fragments, comprising the sequential steps of:

A) disrupting a mycobacterial cell biomass to generate mycobacterial cell wall fragments, mycobacterial cell wall fragments and associated RNA, disrupted mycobacterial cells, intact mycobacterial cells, and mycobacterial RNA;

B) optionally separating intact mycobacterial cells from the generated mycobacterial cell wall fragments and associated RNA; and,

C) separating the soluble, cytosolic contents of a portion of the disrupted mycobacterial cells from the generated mycobacterial cell wall fragments and associated mycobacterial RNA to obtain a composition comprising mycobacterial cell wall fragments and associated RNA,

wherein the composition comprising the isolated mycobacterial RNA associated with the mycobacterial cell wall fragments does not contain phenol or Streptomyces griseus protease.

2. The method of claim 1 , wherein the isolated mycobacterial RNA associated with mycobacterial cell wall fragments is in the form of oligoribonucleotides and polyribonucleotides of about 2 to about 150 bases in length.

3. The method of claim 1 , further comprising after step A, optional step B or after step C a step of heating a composition obtained in a previous step at a temperature sufficient to generate oligoribonucleotides and polyribonucleotides of about 2 to about 150 bases in length, wherein the intact mycobacterial cells are inactivated.

4. The method of claim 1 , wherein the disrupting step A comprises high pressure homogenization at about 10,000 psi or higher.

5. The method of claim 1 , wherein the disrupting step A is repeated 2 to 5 times before the separation steps B or C.

6. The method of claim 1 , further comprising repeating the disrupting step A 2 to 5 times after the separation step C.

7. The method of claim 1 , wherein the separating step B is low speed centrifugation and the separating step C is high speed centrifugation.

8. The method of claim 1 , further comprising:

repeating step A and optionally step B to control the number of the intact mycobacterial cells; and,

after step A, optional step B or after step C a step of heating a composition obtained in a previous step to a temperature sufficient to obtain oligoribonucleotides and polyribonucleotides of about 2 to about 150 bases in length.

9. A method of making a composition comprising isolated bacterial RNA associated with bacterial cell wall fragments comprising the sequential steps of:

A) disrupting a bacterial cell biomass to generate bacterial cell wall fragments, bacterial cell wall fragments and associated RNA, disrupted bacterial cells, intact bacterial cells, and bacterial RNA;

B) optionally separating intact bacterial cells from the generated bacterial cell wall fragments and associated RNA; and,

C) separating the soluble, cytosolic contents of a portion of the disrupted bacterial cells from the generated bacterial cell wall fragments and associated RNA to obtain a composition comprising the bacterial cell wall fragments and associated RNA,

wherein the composition comprising the isolated bacterial RNA associated with bacterial cell wall fragments does not contain phenol or Streptomyces griseus protease.

10. The method of claim 9 , wherein the isolated bacterial RNA associated with bacterial cell wall fragments are from gram positive bacteria or gram negative bacteria.

11. The method of claim 9 , wherein the isolated bacterial RNA associated with bacterial cell wall fragments is in the form of oligoribonucleotides and polyribonucleotides of about 2 to about 150 bases in length.

12. The method of claim 9 , wherein the isolated bacterial RNA associated with bacterial cell wall fragments is in the form of oligoribonucleotides and polyribonucleotides of about 2 to about 40 bases in length.

13. The method of claim 9 , further comprising after step A, optional step B or step C a step of heating a composition obtained in a previous step at a temperature sufficient to generate oligoribonucleotides and polyribonucleotides of about 2 to about 150 bases in length.

14. The method of claim 13 , wherein the intact bacterial cells are inactivated during the step of heating.

15. The method of claim 13 , wherein the temperature is sufficient to generate oligoribonucleotides and polyribonucleotides of about 2 to about 40 bases in length.

16. The method of claim 1 , wherein the mycobacterial cell is selected from the group consisting of Mycobacterium phlei, Mycobacterium vaccae, Mycobacterium smegmatis, Mycobacterium avium subspecies paratuberculosis and Mycobacterium bovis BCG.

17. The method of claim 1 , wherein the mycobacterial cell is Mycobacterium phlei.

18. The method of claim 1 , wherein the isolated mycobacterial RNA associated with bacterial cell wall fragments is in the form of oligoribonucleotides and polyribonucleotides of about 2 to about 40 bases in length.

19. The method of claim 3 , wherein the temperature is sufficient to generate oligoribonucleotides and polyribonucleotides of about 2 to about 40 bases in length.

20. The method of claim 8 , wherein the temperature is sufficient to generate oligoribonucleotides and polyribonucleotides of about 2 to about 40 bases in length.

21. A method of making a composition comprising isolated mycobacterial RNA associated with mycobacterial cell wall fragments, comprising the steps of:

A) disrupting a mycobacterial cell biomass to generate mycobacterial cell wall fragments, mycobacterial cell wall fragments and associated RNA, disrupted mycobacterial cells, intact mycobacterial cells, and mycobacterial RNA;

B) optionally separating intact mycobacterial cells from the generated mycobacterial cell wall fragments and associated RNA;

C) separating the soluble, cytosolic contents of a portion of the disrupted mycobacterial cells from the generated mycobacterial cell wall fragments and associated mycobacterial RNA to obtain a composition comprising mycobacterial cell wall fragments and associated RNA; and,

after step A, optional step B or after step C a step of heating a composition obtained in a previous step at a temperature sufficient to generate oligoribonucleotides and polyribonucleotides of about 2 to about 150 bases in length.

22. The method of claim 21 , wherein the intact mycobacterial cells are inactivated during the step of heating.

23. The method of claim 21 , wherein the composition does not contain phenol or Streptomyces griseus protease.

24. The method of claim 21 , wherein the mycobacterial cell is selected from the group consisting of Mycobacterium phlei, Mycobacterium vaccae, Mycobacterium smegmatis, Mycobacterium avium subspecies paratuberculosis and Mycobacterium bovis BCG.

25. The method of claim 21 , wherein the mycobacterial cell is Mycobacterium phlei.

26. The method of claim 21 , wherein the disrupting step A comprises high pressure homogenization at about 10,000 psi or higher.

27. The method of claim 21 , wherein the disrupting step A is repeated 2 to 5 times before the separation steps B or C.

28. The method of claim 21 , further comprising repeating the disrupting step A 2 to 5 times after the separation step C.

29. The method of claim 21 , wherein the separating step B is low speed centrifugation and the separating step C is high speed centrifugation.

30. The method of claim 21 , further comprising repeating step A and optionally step B to control the number of the intact mycobacterial cells.

31. The method of claim 21 , wherein the temperature is sufficient to generate oligoribonucleotides and polyribonucleotides of about 2 to about 40 bases in length.

32. A method of making a composition comprising isolated bacterial RNA associated with bacterial cell wall fragments comprising the steps of:

A) disrupting a bacterial cell biomass to generate bacterial cell wall fragments, bacterial cell wall fragments and associated RNA, disrupted bacterial cells, intact bacterial cells, and bacterial RNA;

B) optionally separating intact bacterial cells from the generated bacterial cell wall fragments and associated RNA;

C) separating the soluble, cytosolic contents of a portion of the disrupted bacterial cells from the generated bacterial cell wall fragments and associated RNA to obtain a composition comprising bacterial cell wall fragments and associated RNA; and,

after step A, optional step B or step C a step of heating a composition obtained in a previous step at a temperature sufficient to generate oligoribonucleotides and polyribonucleotides of about 2 to about 150 bases in length.

33. The method of claim 32 , wherein the composition comprising the isolated bacterial RNA associated with bacterial cell wall fragments does not contain phenol or Streptomyces griseus protease.

34. The method of claim 32 , wherein the isolated bacterial RNA associated with bacterial cell wall fragments are from gram positive bacteria or gram negative bacteria.

35. The method of claim 32 , wherein the intact bacterial cells are inactivated during the step of heating.

36. The method of claim 32 , wherein the temperature is sufficient to generate oligoribonucleotides and polyribonucleotides of about 2 to about 40 bases in length.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 036986 FRAME: 0343. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Dec 1, 2015
From: BIONICHE UROLOGY IP INC.
To: TELESTA THERAPEUTICS IP INC.
Reel/Frame 037177/0450 →
CHANGE OF NAME Recorded Oct 28, 2015
From: BIONICHE UROLOGY IP INC.
To: TELESTA THERAPEUTICS IP INC.
Reel/Frame 036986/0343 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2014
From: PHILLIPS, NIGEL C.; KE, DANBING; HOLAN, ZDENEK RICHARD; FILION, MARIO C.; ELRAFIH, MOHAMED; VELJI, IQUBAL
To: BIONICHE LIFE SCIENCES INC.
Reel/Frame 032293/0510 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2014
From: BIONICHE LIFE SCIENCES INC.
To: BIONICHE UROLOGY IP INC.
Reel/Frame 032293/0523 →
Continuity (4)
Division 13701954
Provisional Application 61392498 · Oct 13, 2010
Provisional Application 61393589 · Oct 15, 2010
Related Publication 20140322372A1 · Oct 30, 2014